Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

JNGLX vs AGNG overlap: 21% of top holdings shared

Bottom line

How much do JNGLX and AGNG overlap?

21% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 26.1% of JNGLX's assets and 18.3% of AGNG's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

JNGLXAGNG
Weight overlap (top 25)21%
Shared holdings6
Weight in shared holdings26.1%18.3%
Total positions10884
Expense ratio0.81%0.5%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings JNGLX and AGNG have in common

Holding% of JNGLX% of AGNGOverlap
Eli Lilly & Co.9.41%3.58%3.58%
Johnson & Johnson7.09%2.88%2.88%
AbbVie, Inc.4.67%3.16%3.16%
Merck & Co., Inc.1.87%2.99%1.87%
Amgen, Inc.1.64%2.93%1.64%
Stryker Corp.1.41%2.78%1.41%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in JNGLX

  1. UnitedHealth Group, Inc. — 4.54%
  2. AstraZeneca plc — 3.93%
  3. Revolution Medicines, Inc. — 3.02%
  4. Argenx SE — 2.63%
  5. Novartis AG — 2.56%
  6. Thermo Fisher Scientific, Inc. — 2.33%
  7. Praxis Precision Medicines, Inc. — 2.19%
  8. Bridgebio Pharma, Inc. — 2.04%
  9. CVS Health Corp. — 2.02%
  10. Roche Holding AG — 2.01%
  11. Intuitive Surgical, Inc. — 1.94%
  12. Abbott Laboratories — 1.86%
  13. Vertex Pharmaceuticals, Inc. — 1.69%
  14. Ascendis Pharma A/S — 1.68%
  15. Danaher Corp. — 1.65%

Only in AGNG

  1. Novo Nordisk A/s — 3.80%
  2. Edwards Lifesciences Corporation — 3.37%
  3. Roche Holding AG — 3.21%
  4. Welltower Inc. — 3.07%
  5. Ventas, Inc. — 3.06%
  6. Bristol-myers Squibb Company — 2.98%
  7. Ucb Sa — 2.86%
  8. Astrazeneca Plc — 2.80%
  9. Chugai Pharmaceutical Co., Ltd. — 2.78%
  10. Sandoz Group AG — 2.62%
  11. Medtronic Public Limited Company — 2.60%
  12. Regeneron Pharmaceuticals, Inc. — 2.48%
  13. Boston Scientific Corporation — 2.44%
  14. Alcon AG — 2.35%
  15. BeOne Medicines AG — 2.24%

Asset mix

Asset typeJNGLXAGNG
Stocks99.1%99.7%
Cash & short-term funds0.9%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryJNGLXAGNG
US80.1%61.7%
CH4.6%11.4%
JP—6.5%
DK1.7%5.9%
GB3.9%0.9%
HK—3.7%
BE0.6%3.4%
NL2.6%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do JNGLX and AGNG overlap?
About 21% by weight. 6 securities appear in both funds' top 25 holdings; they make up 26.1% of JNGLX's assets and 18.3% of AGNG's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do JNGLX and AGNG have in common?
The largest shared holdings are Eli Lilly & Co., AbbVie, Inc., Johnson & Johnson, Merck & Co., Inc., Amgen, Inc..
Should I own both JNGLX and AGNG?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, JNGLX or AGNG?
JNGLX is broader, with 108 positions versus 84 for AGNG. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.